CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −502 | $509.22 | $256K | 47,279 |
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −138 | $509.81 | $70K | 47,141 |
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −40 | $510.64 | $20K | 47,101 |
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,877 | $512.59 | $1.5M | 44,224 |
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −4,713 | $513.46 | $2.4M | 39,511 |
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,650 | $514.18 | $1.4M | 36,861 |
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −80 | $516.06 | $41K | 36,781 |
| 2025-12-24 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −11,000 | 9,250 | ||
| 2025-12-23 | MALCOLM JAN Director | Sale 10b5-1 | −50 | $512.12 | $26K | 420 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | −14,625 | $117.76 | $1.7M | 14,625 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −682 | $512.14 | $349K | 13,943 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −848 | $513.40 | $435K | 13,095 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −11,815 | $514.31 | $6.1M | 1,280 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −440 | $515.53 | $227K | 840 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −560 | $516.37 | $289K | 280 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −200 | $517.74 | $104K | 80 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −80 | $518.91 | $42K | 0 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +6,190 | $146.03 | $904K | 6,190 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +1,685 | $146.03 | $246K | 7,875 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −120 | $511.67 | $61K | 7,755 |
Page 165 of 171 · 3,408 trades